D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Net Income -8.36M 11.75M -3.05M -1.47M 23.42M
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 7.32M -14.05M 2.11M 864.20K -23.92M
Change in Net Operating Assets -954.80K 1.26M 422.20K -449.30K 125.70K
Cash from Operations -1.99M -1.04M -509.90K -1.05M -373.30K
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 0.00 0.00 0.00 -7.00M
Cash from Investing -- 0.00 0.00 0.00 -7.00M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -171.50K -225.00K -1.40M -742.20K
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- 0.00 -3.72M -9.34M -9.43M
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -- -171.50K -3.95M -10.74M -10.17M
Foreign Exchange rate Adjustments 100.00 600.00 -1.20K 100.00 200.00
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -1.99M -1.21M -4.46M -11.80M -17.54M